Overview

What they do
Early stage and growth equity investments in Life Sciences, TechBio, Healthtech and Diagnostics. There is enormous opportunity in the life sciences, tech bio and healthtech spaces across all investment stages. The next medical breakthroughs will come from combining incredible new technologies with a greater understanding of biology. AVANT BIO LLC was launched to invest in these opportunities and was structured to attract institutional capital interested in these spaces.
avant.bio
What they look for
AVANT BIO focuses on the "enabling technologies" that shape how tomorrow's therapeutics are discovered, developed, and manufactured. Their thesis is built on the belief that the next medical breakthroughs will come from combining incredible new technologies (like AI, machine learning, and robotics) with a greater understanding of biology.
avant.bio
Stage
Seed, Series A, Series B+
avant.bio
Sectors
Healthcare, AI, Deeptech
avant.bio
Based
New York, US
avant.bio

Sources

2026-08-30avant.bioAVANT BIO Emerges as a Leading Equity Firm in Life Sciences, Tech Bio, and Health Tech
2026-08-30avant.bioThis aligns with AVANT BIO’s core thesis: Tomorrow’s’ cures rely on today’s…
2026-08-30avant.bioCongratulations to our portfolio company, Nomic Bio , on awarding their first Omni 1000 Grant…

Portfolio, cheque size and the rest

The 5 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.